Showing results (911-920 of 1,271) with videos related to
Sort By:
Pageof 128
Psychopharmacology Bulletin|January 14, 2026
Lorazepam-Assisted Interview in Clinical Psychiatry: A Narrative Review of Current Evidence and Research GapsOmar Afroz, Raja Babu Ramawat, Romil Saini, et al.Psychopharmacology Bulletin|January 14, 2026
Emerging Innovations in Third- and Fourth-Generation Antipsychotics: Mechanistic Advances and Clinical ImplicationsAdel Awadh BaeissaPsychopharmacology Bulletin|January 14, 2026
Risk of Obesity in Patients Treated with Clozapine or Olanzapine: A Simple, Clinically Useful Prediction ToolRoberto Lozano, Carina BonaPsychopharmacology Bulletin|March 6, 2023
Treatment of Parental Depression and Reduced Risk in Offspring-Does It Have Anything to Do with Offspring Gender?Bibi Alamiri, Ahmed NaguyPsychopharmacology Bulletin|August 1, 2020
Impact of Polymorphism of CYP2D6 on Equilibrium Concentration of Duloxetine in Patients Suffering from Major Depressive DisorderZastrozhin, Petukhov, Pankratenko, et al.Psychopharmacology Bulletin|August 1, 2020
The Influence of Concentration of Micro-RNA hsa-miR-370-3p and CYP2D6*4 on Equilibrium Concentration of Mirtazapine in Patients With Major Depressive DisorderZastrozhin, Smirnov, Petukhov, et al.Psychopharmacology Bulletin|August 1, 2020
Naldemedine for the Use of Management of Opioid Induced ConstipationIvan Urits, Anjana Patel, Hayley Cornwall Kiernan, et al.Psychopharmacology Bulletin|January 1, 1989
Subjective symptoms: part of the negative syndrome of schizophrenia?I Bitter, J Jaeger, J Agdeppa, et al.Psychopharmacology Bulletin|January 1, 1989
Choice of rating form for evaluating anxiolyticsR I Wang, C KocharPsychopharmacology Bulletin|January 1, 1989
Actions of typical and atypical antipsychotics on tuberoinfundibular dopamine neuronsG A Gudelsky, S A Berry, H Y MeltzerPageof 128